Delivery Order SPE2DB25D3306-SPE2DB25FUBWG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,819.97 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,782.89 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml formulation) under a firm fixed-price contract. This award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) prefilled pens with a ceiling value of $53,874.20. The contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025, and utilized firm fixed-price pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $17,435.30 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a $49,303 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,712.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) pre-filled pens on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $8,353.13 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). This is a firm fixed-price contract with a completion date of April 24, 2025, and was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25–0.5 mg/dose pens (3 mL) with a contract value of $8,698.33 under a firm fixed-price arrangement. The award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at approximately $22K, with an ultimate completion date of September 3, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,661.03 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL). This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBWGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,128.45 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed price contract. The award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location in the same area. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for the diabetes medication Ozempic exemplifies the type of critical pharmaceutical commodity delivered through this expansive contract framework to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 6/2/25 |